45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
18,506
Insurances with rates
20
CPT / HCPCS codes
17,390
Most expensive procedures (gross)
J3245
$22,916
TILDRAKIZUMAB-ASMN 100 MG/ML SYRINGE
Gross
$22,916
J3245
$22,916
All Inpatient Services
Gross
$22,916
J2327
$22,350
RISANKIZUMAB-RZAA 600 MG/10 ML VIAL
Gross
$22,350
J9334
$20,528
EFGARTIGIMOD-HYALURONIDAS-QVFC 1,008 MG/5.6 ML VIAL
Gross
$20,528
J3380
$18,320
VEDOLIZUMAB 300 MG/5 ML VIAL
Gross
$18,320
J9144
$14,062
DARATUMUMAB-HYALURONIDASE-FIHJ 15 ML VIAL
Gross
$14,062
J9144
$14,062
All Outpatient Services
Gross
$14,062
J2406
$13,122
ORITAVANCIN DIPHOSPHATE 1,200 MG VIAL
Gross
$13,122
0278
$12,739
ANCHOR/SCREW BN/BN,TIS/BN
Gross
$12,739
C1713
$12,739
ANCHOR/SCREW BN/BN,TIS/BN
Gross
$12,739
0278
$12,739
All Outpatient Services
Gross
$12,739
J1569
$12,208
All Outpatient Services
Gross
$12,208
J0717
$11,039
CERTOLIZUMAB PEGOL 400 MG/2 ML SYRINGEKIT
Gross
$11,039
J3101
$11,015
TENECTEPLASE 50 MG/10 ML KIT
Gross
$11,015
J0517
$10,554
BENRALIZUMAB 30 MG/ML SYRINGE
Gross
$10,554
J2997
$10,132
ALTEPLASE 100MG/100ML VIA
Gross
$10,132
J1449
$8,590
EFLAPEGRASTIM-XNST 13.2 MG/0.6 ML SYRINGE
Gross
$8,590
J2353
$8,417
OCTREOTIDE ACETATE,MI-SPHERES 20 MG VIAL
Gross
$8,417
J9310
$8,236
RITUXIMAB 500 MG/50 ML VIAL
Gross
$8,236
C1889
$8,050
All Outpatient Services
Gross
$8,050
J2356
$8,043
TEZEPELUMAB-EKKO 210 MG/1.91 ML SYRINGE
Gross
$8,043
J2356
$8,043
All Outpatient Services
Gross
$8,043
J2278
$8,033
ZICONOTIDE ACETATE 25 MCG/ML VIAL
Gross
$8,033
J2278
$8,033
All Outpatient Services
Gross
$8,033
Q5115
$7,418
RITUXIMAB-ABBS 500 MG/50 ML VIAL
Gross
$7,418
Q5111
$7,321
PEGFILGRASTIM-CBQV 6 MG/0.6 ML SYRINGE
Gross
$7,321
Q5111
$7,321
All Outpatient Services
Gross
$7,321
J1306
$6,806
INCLISIRAN SODIUM 284 MG/1.5 ML SYRINGE
Gross
$6,806
J1306
$6,806
All Outpatient Services
Gross
$6,806
36475
$6,645
IR ENDOVENOUS RF 1ST VEIN
Gross
$6,645
36475
$6,645
All Outpatient Services
Gross
$6,645
J2182
$6,575
MEPOLIZUMAB--NUCALA 100 MG VIAL
Gross
$6,575
J2182
$6,575
All Outpatient Services
Gross
$6,575
27792
$6,534
TREATMENT OF ANKLE FRACTURE
Gross
$6,534
J2353
$6,428
OCTREOTIDE ACETATE,MI-SPHERES 10 MG VIAL
Gross
$6,428
J2426
$6,411
PALIPERIDONE PALMITATE 234 MG/1.5 ML DISP.SYRIN
Gross
$6,411
64635
$6,396
BILAT RFA LUMBAR OR SACRAL
Gross
$6,396
J0897
$6,233
DENOSUMAB 120 MG/1.7 ML VIAL
Gross
$6,233
Q4316
$6,210
All Outpatient Services
Gross
$6,210
64633
$6,203
BILAT RFA CERVICAL OR THORACIC
Gross
$6,203
64636
$6,032
BILAT RFA LUMBAR OR SACRAL ADD
Gross
$6,032
J3262
$5,985
TOCILIZUMAB 400 MG/20 ML VIAL
Gross
$5,985
J1942
$5,918
ARIPIPRAZOLE LAUROXIL 882 MG/3.2 ML SUSER.SYR
Gross
$5,918
J1942
$5,918
All Outpatient Services
Gross
$5,918
J2505
$5,510
PEGFILGRASTIM 6MG/0.6ML S
Gross
$5,510
J2505
$5,510
All Inpatient Services
Gross
$5,510
59618
$5,472
ATTEMPTED VBAC DELIVERY
Gross
$5,472
J2357
$5,453
OMALIZUMAB 300 MG/2 ML SYRINGE
Gross
$5,453
59510
$5,421
ROUTINE OB CARE WITH C-SECTION
Gross
$5,421
J9217
$5,150
LEUPROLIDE ACETATE 30 MG
Gross
$5,150
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SYRINGE | $22,916 | $22,916 | — | — | 14 |
| J3245 | All Inpatient Services | $22,916 | $22,916 | — | — | 0 |
| J2327 | RISANKIZUMAB-RZAA 600 MG/10 ML VIAL | $22,350 | $22,350 | — | — | 10 |
| J9334 | EFGARTIGIMOD-HYALURONIDAS-QVFC 1,008 MG/5.6 ML VIAL | $20,528 | $20,528 | — | — | 9 |
| J3380 | VEDOLIZUMAB 300 MG/5 ML VIAL | $18,320 | $18,320 | — | — | 14 |
| J9144 | DARATUMUMAB-HYALURONIDASE-FIHJ 15 ML VIAL | $14,062 | $14,062 | — | — | 13 |
| J9144 | All Outpatient Services | $14,062 | $14,062 | — | — | 0 |
| J2406 | ORITAVANCIN DIPHOSPHATE 1,200 MG VIAL | $13,122 | $13,122 | — | — | 18 |
| 0278 | ANCHOR/SCREW BN/BN,TIS/BN | $12,739 | $12,739 | — | — | 14 |
| C1713 | ANCHOR/SCREW BN/BN,TIS/BN | $12,739 | $12,739 | — | — | 16 |
| 0278 | All Outpatient Services | $12,739 | $12,739 | — | — | 0 |
| J1569 | All Outpatient Services | $12,208 | $12,208 | — | — | 0 |
| J0717 | CERTOLIZUMAB PEGOL 400 MG/2 ML SYRINGEKIT | $11,039 | $11,039 | — | — | 12 |
| J3101 | TENECTEPLASE 50 MG/10 ML KIT | $11,015 | $11,015 | — | — | 14 |
| J0517 | BENRALIZUMAB 30 MG/ML SYRINGE | $10,554 | $10,554 | — | — | 16 |
| J2997 | ALTEPLASE 100MG/100ML VIA | $10,132 | $10,132 | — | — | 17 |
| J1449 | EFLAPEGRASTIM-XNST 13.2 MG/0.6 ML SYRINGE | $8,590 | $8,590 | — | — | 15 |
| J2353 | OCTREOTIDE ACETATE,MI-SPHERES 20 MG VIAL | $8,417 | $8,417 | — | — | 13 |
| J9310 | RITUXIMAB 500 MG/50 ML VIAL | $8,236 | $8,236 | — | — | 14 |
| C1889 | All Outpatient Services | $8,050 | $8,050 | — | — | 0 |
| J2356 | TEZEPELUMAB-EKKO 210 MG/1.91 ML SYRINGE | $8,043 | $8,043 | — | — | 10 |
| J2356 | All Outpatient Services | $8,043 | $8,043 | — | — | 0 |
| J2278 | ZICONOTIDE ACETATE 25 MCG/ML VIAL | $8,033 | $8,033 | — | — | 12 |
| J2278 | All Outpatient Services | $8,033 | $8,033 | — | — | 0 |
| Q5115 | RITUXIMAB-ABBS 500 MG/50 ML VIAL | $7,418 | $7,418 | — | — | 14 |
| Q5111 | PEGFILGRASTIM-CBQV 6 MG/0.6 ML SYRINGE | $7,321 | $7,321 | — | — | 11 |
| Q5111 | All Outpatient Services | $7,321 | $7,321 | — | — | 0 |
| J1306 | INCLISIRAN SODIUM 284 MG/1.5 ML SYRINGE | $6,806 | $6,806 | — | — | 9 |
| J1306 | All Outpatient Services | $6,806 | $6,806 | — | — | 0 |
| 36475 | IR ENDOVENOUS RF 1ST VEIN | $6,645 | $6,645 | — | — | 11 |
| 36475 | All Outpatient Services | $6,645 | $6,645 | — | — | 0 |
| J2182 | MEPOLIZUMAB--NUCALA 100 MG VIAL | $6,575 | $6,575 | — | — | 12 |
| J2182 | All Outpatient Services | $6,575 | $6,575 | — | — | 0 |
| 27792 | TREATMENT OF ANKLE FRACTURE | $6,534 | $6,534 | — | — | 27 |
| J2353 | OCTREOTIDE ACETATE,MI-SPHERES 10 MG VIAL | $6,428 | $6,428 | — | — | 12 |
| J2426 | PALIPERIDONE PALMITATE 234 MG/1.5 ML DISP.SYRIN | $6,411 | $6,411 | — | — | 12 |
| 64635 | BILAT RFA LUMBAR OR SACRAL | $6,396 | $6,396 | — | — | 23 |
| J0897 | DENOSUMAB 120 MG/1.7 ML VIAL | $6,233 | $6,233 | — | — | 11 |
| Q4316 | All Outpatient Services | $6,210 | $6,210 | — | — | 0 |
| 64633 | BILAT RFA CERVICAL OR THORACIC | $6,203 | $6,203 | — | — | 28 |
| 64636 | BILAT RFA LUMBAR OR SACRAL ADD | $6,032 | $6,032 | — | — | 20 |
| J3262 | TOCILIZUMAB 400 MG/20 ML VIAL | $5,985 | $5,985 | — | — | 15 |
| J1942 | ARIPIPRAZOLE LAUROXIL 882 MG/3.2 ML SUSER.SYR | $5,918 | $5,918 | — | — | 15 |
| J1942 | All Outpatient Services | $5,918 | $5,918 | — | — | 0 |
| J2505 | PEGFILGRASTIM 6MG/0.6ML S | $5,510 | $5,510 | — | — | 15 |
| J2505 | All Inpatient Services | $5,510 | $5,510 | — | — | 0 |
| 59618 | ATTEMPTED VBAC DELIVERY | $5,472 | $5,472 | — | — | 9 |
| J2357 | OMALIZUMAB 300 MG/2 ML SYRINGE | $5,453 | $5,453 | — | — | 12 |
| 59510 | ROUTINE OB CARE WITH C-SECTION | $5,421 | $5,421 | — | — | 11 |
| J9217 | LEUPROLIDE ACETATE 30 MG | $5,150 | $5,150 | — | — | 14 |
Showing top 50 of 18,506 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.